Lewei A Lin1, Mark A Ilgen2, Mary Jannausch2, Kipling M Bohnert2. 1. University of Michigan, Department of Psychiatry, Addiction Center, North Campus Research Complex 2800 Plymouth Road, Ann Arbor, MI 48109, United States. Electronic address: leweil@med.umich.edu. 2. University of Michigan, Department of Psychiatry, Addiction Center, North Campus Research Complex 2800 Plymouth Road, Ann Arbor, MI 48109, United States; VA Center for Clinical Management Research (CCMR), Department of Veterans Affairs Healthcare System, Ann Arbor MI, North Campus Research Complex, 2800 Plymouth Rd, Ann Arbor, MI 48109, United States.
Abstract
OBJECTIVES: Cannabis has been legalized for medical use in almost half of the states in the U.S. Although laws in these states make the distinction between medical and recreational use of cannabis, the prevalence of people using medical cannabis and how distinct this group is from individuals using cannabis recreationally is unknown at a national level. METHODS: Data came from the 2013 National Survey on Drug Use and Health (NSDUH). All adults endorsing past year cannabis use who reported living in a state that had legalized medical cannabis were divided into recreational cannabis use only and medical cannabis use. Demographic and clinical characteristics were compared across these two groups. RESULTS: 17% of adults who used cannabis in the past year used cannabis medically. There were no significant differences between those who used medically versus recreationally in race, education, past year depression and prevalence of cannabis use disorders. In adjusted analyses, those with medical cannabis use were more likely to have poorer health and lower levels of alcohol use disorders and non-cannabis drug use. A third of those who reported medical cannabis use endorsed daily cannabis use compared to 11% in those who reported recreational use exclusively. CONCLUSIONS: Adults who use medical and recreational cannabis shared some characteristics, but those who used medical cannabis had higher prevalence of poor health and daily cannabis use. As more states legalize cannabis for medical use, it is important to better understand similarities and differences between people who use cannabis medically and recreationally.
OBJECTIVES: Cannabis has been legalized for medical use in almost half of the states in the U.S. Although laws in these states make the distinction between medical and recreational use of cannabis, the prevalence of people using medical cannabis and how distinct this group is from individuals using cannabis recreationally is unknown at a national level. METHODS: Data came from the 2013 National Survey on Drug Use and Health (NSDUH). All adults endorsing past year cannabis use who reported living in a state that had legalized medical cannabis were divided into recreational cannabis use only and medical cannabis use. Demographic and clinical characteristics were compared across these two groups. RESULTS: 17% of adults who used cannabis in the past year used cannabis medically. There were no significant differences between those who used medically versus recreationally in race, education, past year depression and prevalence of cannabis use disorders. In adjusted analyses, those with medical cannabis use were more likely to have poorer health and lower levels of alcohol use disorders and non-cannabis drug use. A third of those who reported medical cannabis use endorsed daily cannabis use compared to 11% in those who reported recreational use exclusively. CONCLUSIONS: Adults who use medical and recreational cannabis shared some characteristics, but those who used medical cannabis had higher prevalence of poor health and daily cannabis use. As more states legalize cannabis for medical use, it is important to better understand similarities and differences between people who use cannabis medically and recreationally.
Authors: Marcel O Bonn-Miller; Matthew Tyler Boden; Meggan M Bucossi; Kimberly A Babson Journal: Am J Drug Alcohol Abuse Date: 2013-11-08 Impact factor: 3.829
Authors: Marina Goldman; Jesse J Suh; Kevin G Lynch; Regina Szucs; Jennifer Ross; Hu Xie; Charles P O'Brien; David W Oslin Journal: J Addict Med Date: 2010-03 Impact factor: 3.702
Authors: Melissa K Richmond; Fred C Pampel; Laura S Rivera; Kerryann B Broderick; Brie Reimann; Leigh Fischer Journal: J Psychoactive Drugs Date: 2015 Jan-Mar
Authors: John R Hughes; James R Fingar; Alan J Budney; Shelly Naud; John E Helzer; Peter W Callas Journal: Addict Behav Date: 2014-06-04 Impact factor: 3.913
Authors: Deborah S Hasin; Tulshi D Saha; Bradley T Kerridge; Risë B Goldstein; S Patricia Chou; Haitao Zhang; Jeesun Jung; Roger P Pickering; W June Ruan; Sharon M Smith; Boji Huang; Bridget F Grant Journal: JAMA Psychiatry Date: 2015-12 Impact factor: 21.596
Authors: Jane Metrik; Rachel L Gunn; Kristina M Jackson; Alexander W Sokolovsky; Brian Borsari Journal: Alcohol Clin Exp Res Date: 2018-05-08 Impact factor: 3.455
Authors: Erin E Bonar; James A Cranford; Brooke J Arterberry; Maureen A Walton; Kipling M Bohnert; Mark A Ilgen Journal: Drug Alcohol Depend Date: 2019-01-09 Impact factor: 4.492
Authors: Kevin F Boehnke; J Ryan Scott; Evangelos Litinas; Suzanne Sisley; David A Williams; Daniel J Clauw Journal: J Pain Date: 2019-09-24 Impact factor: 5.820
Authors: Ryan K McBain; Eunice C Wong; Joshua Breslau; Amy L Shearer; Matthew S Cefalu; Elizabeth Roth; M Audrey Burnam; Rebecca L Collins Journal: Drug Alcohol Depend Date: 2020-07-24 Impact factor: 4.492
Authors: Patrick M Azcarate; Alysandra J Zhang; Salomeh Keyhani; Stacey Steigerwald; Julie H Ishida; Beth E Cohen Journal: J Gen Intern Med Date: 2020-04-06 Impact factor: 5.128
Authors: Douglas Bruce; Alida M Bouris; Shannon Bowers; Olivia Blocker; Soo Young Lee; Mary F Glidden; John A Schneider; Daniel H Reirden Journal: Addict Res Theory Date: 2019-06-26